Parkinson’s Foundation researchers and other scientists worldwide make continual advances in understanding Parkinson’s disease (PD) with revolutionary research. We monitor it all in our effort to improving care and advance research toward a cure. Browse our collection here:
Two clinical studies investigating a class of type 2 diabetes drugs for Parkinson’s disease (PD) are helping scientists to better understand PD and if there are possible uses for these drugs. The studies respectively found that extended treatment with one specific drug does not improve PD symptoms, but that people who take one in the class of drugs may have a lower risk of PD.